Skip to main content

Assembly Biosciences, Inc.

ASMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001426800

No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Assembly Biosciences, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ASMB: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5040−10
Shares16.6M14.2M−2.40M (−14.5%)
Value$27.2M$18.4M−$8.77M (−32.2%)

New holders (2)

Institutions that held Assembly Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ASMB in Q4 2022
InstitutionSharesValue% of portfolio
Squarepoint Ops LLC10,485$13.6K0.00%
Advisory Services Network, LLC1$10.00%

Sold out (12)

Institutions that held Assembly Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ASMB in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Healthcare of Ontario Pension Plan Trust Fund570,300$935.0K
Assenagon Asset Management S.A.253,783$416.0K
Marquette Asset Management, LLC58,246$96.0K
Algert Global LLC41,890$69.0K
Two Sigma Investments, LP32,067$53.0K
Virtu Financial LLC30,046$49.0K
Cubist Systematic Strategies, LLC19,857$33.0K
Prudential Financial Inc19,780$32.0K
Occudo Quantitative Strategies LP12,440$20.0K
Running Point Capital Advisors, LLC10,000$16.0K
Simplex Trading, LLC2,703$4.00K
Royal Bank of Canada187$0